Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Suspected Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05940415
What this trial is testing

Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 220
Testing effectiveness (Phase 2)Ended earlyNCT05712174
What this trial is testing

[18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Who this might be right for
OncologyProstate Cancer
AHS Cancer Control Alberta 176
Large-scale testing (Phase 3)Study completedNCT04644822
What this trial is testing

Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Who this might be right for
Prostate Cancer RecurrentRecurrent Prostate Cancer
Centre for Probe Development and Commercialization 100
Testing effectiveness (Phase 2)Study completedNCT01076335
What this trial is testing

Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Not applicableActive Not RecruitingNCT06824259
What this trial is testing

The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Peking University First Hospital 400
Large-scale testing (Phase 3)Study completedNCT02659527
What this trial is testing

PET/MRI in Patients With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna 220
Not applicableActive Not RecruitingNCT01653093
What this trial is testing

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
University of Cincinnati 280
Large-scale testing (Phase 3)Looking for participantsNCT06754085
What this trial is testing

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer
HTA Co., Ltd. 131
Large-scale testing (Phase 3)Looking for participantsNCT07831824
What this trial is testing

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 408
Not applicableStudy completedNCT05763355
What this trial is testing

Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic

Who this might be right for
Patients With Suspected Prostate Cancer
Elsan 101
Not applicableStudy completedNCT02131649
What this trial is testing

PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 99
Not applicableEnded earlyNCT06655064
What this trial is testing

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Telix Pharmaceuticals (Innovations) Pty Limited 120
Not applicableUnknownNCT01819740
What this trial is testing

Analysis of a New Biomarker for Prostate Cancer Diagnosis

Who this might be right for
Patients With Suspected Prostate Cancer
Corporacion Parc Tauli 28
Not applicableStudy completedNCT01357512
What this trial is testing

Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University of Oulu 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT06922929
What this trial is testing

A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

Who this might be right for
Prostate Cancer Recurrent
Yunhe Pharmaceutical (Tianjin) Co., Ltd 110
Not applicableStudy completedNCT02745496
What this trial is testing

Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
University of Dundee 603
Large-scale testing (Phase 3)Study completedNCT06235099
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate
Curium US LLC 235
Not applicableUnknownNCT05192252
What this trial is testing

Correlation Between Seminal Vesicle Size and Duration of Sexual Abstinence

Who this might be right for
Suspected Prostate Cancer
Fondation Hôpital Saint-Joseph 250
Not applicableLooking for participantsNCT07531329
What this trial is testing

Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer

Who this might be right for
Treatment-naive Prostate CancerSuspected Prostate CancerMolecular Imaging
Xijing Hospital 1,000
Next Page